 Ritsuko Iwanaga
Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| E2F1 Transcription Factor | 9 | 2023 | 57 | 1.160 |
Why?
| | Positive Regulatory Domain I-Binding Factor 1 | 1 | 2020 | 15 | 0.710 |
Why?
| | Melanocytes | 1 | 2020 | 55 | 0.690 |
Why?
| | Zebrafish Proteins | 1 | 2020 | 246 | 0.590 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2020 | 1141 | 0.580 |
Why?
| | Zebrafish | 1 | 2020 | 411 | 0.540 |
Why?
| | Ligaments | 1 | 2016 | 45 | 0.520 |
Why?
| | Pelvis | 1 | 2016 | 90 | 0.500 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2020 | 800 | 0.500 |
Why?
| | E2F Transcription Factors | 6 | 2023 | 55 | 0.500 |
Why?
| | Uterus | 1 | 2016 | 192 | 0.480 |
Why?
| | Vagina | 1 | 2016 | 146 | 0.470 |
Why?
| | Models, Animal | 1 | 2016 | 344 | 0.460 |
Why?
| | Homeodomain Proteins | 3 | 2012 | 463 | 0.450 |
Why?
| | Melanoma | 1 | 2020 | 619 | 0.450 |
Why?
| | Transforming Growth Factor beta | 2 | 2012 | 448 | 0.400 |
Why?
| | Gene Expression Regulation | 6 | 2023 | 2319 | 0.400 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 157 | 0.380 |
Why?
| | Neoplastic Stem Cells | 3 | 2014 | 329 | 0.350 |
Why?
| | Promoter Regions, Genetic | 10 | 2023 | 1131 | 0.340 |
Why?
| | Breast Neoplasms | 3 | 2014 | 1862 | 0.280 |
Why?
| | Genes, Tumor Suppressor | 4 | 2023 | 77 | 0.260 |
Why?
| | Growth Substances | 1 | 2004 | 138 | 0.240 |
Why?
| | Fibroblasts | 5 | 2018 | 837 | 0.230 |
Why?
| | DNA Repair | 1 | 2004 | 184 | 0.210 |
Why?
| | Transcription Factor DP1 | 2 | 2023 | 21 | 0.210 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2023 | 40 | 0.210 |
Why?
| | Signal Transduction | 3 | 2016 | 4509 | 0.190 |
Why?
| | Tumor Suppressor Proteins | 2 | 2014 | 282 | 0.190 |
Why?
| | Tumor Suppressor Protein p14ARF | 2 | 2014 | 6 | 0.180 |
Why?
| | Neoplasms | 3 | 2023 | 2097 | 0.180 |
Why?
| | Cell Line, Tumor | 8 | 2016 | 2710 | 0.180 |
Why?
| | Prognosis | 3 | 2020 | 3328 | 0.180 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p18 | 2 | 2016 | 11 | 0.170 |
Why?
| | Bcl-2-Like Protein 11 | 2 | 2016 | 37 | 0.170 |
Why?
| | Proto-Oncogene Proteins | 2 | 2015 | 608 | 0.140 |
Why?
| | Genes, p16 | 1 | 2016 | 16 | 0.140 |
Why?
| | Cell Cycle Proteins | 4 | 2023 | 551 | 0.140 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 107 | 0.130 |
Why?
| | Connective Tissue | 1 | 2016 | 36 | 0.130 |
Why?
| | DNA-Binding Proteins | 4 | 2018 | 1314 | 0.130 |
Why?
| | Survival Rate | 1 | 2020 | 1644 | 0.130 |
Why?
| | Apoptosis | 7 | 2023 | 2362 | 0.130 |
Why?
| | Pelvic Organ Prolapse | 1 | 2016 | 39 | 0.130 |
Why?
| | Disease Progression | 2 | 2020 | 2380 | 0.130 |
Why?
| | Muscle, Smooth | 1 | 2016 | 144 | 0.120 |
Why?
| | Animals | 7 | 2020 | 31694 | 0.120 |
Why?
| | Vascular Endothelial Growth Factor C | 1 | 2014 | 16 | 0.120 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 329 | 0.120 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2015 | 171 | 0.120 |
Why?
| | Nuclear Proteins | 2 | 2012 | 591 | 0.120 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2018 | 445 | 0.120 |
Why?
| | Neoplasms, Experimental | 1 | 2014 | 151 | 0.110 |
Why?
| | Cell Differentiation | 1 | 2020 | 1700 | 0.110 |
Why?
| | Superoxide Dismutase | 1 | 2014 | 305 | 0.100 |
Why?
| | Cells, Cultured | 1 | 2020 | 3881 | 0.100 |
Why?
| | Antibodies, Neoplasm | 1 | 2012 | 30 | 0.100 |
Why?
| | Heterografts | 1 | 2012 | 117 | 0.100 |
Why?
| | Cell Line | 4 | 2018 | 2635 | 0.100 |
Why?
| | Humans | 17 | 2023 | 114623 | 0.100 |
Why?
| | Rats, Sprague-Dawley | 1 | 2016 | 2218 | 0.090 |
Why?
| | Cluster Analysis | 1 | 2012 | 455 | 0.090 |
Why?
| | Mice | 4 | 2016 | 14860 | 0.090 |
Why?
| | Membrane Proteins | 1 | 2015 | 1018 | 0.080 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2008 | 69 | 0.080 |
Why?
| | Response Elements | 2 | 2008 | 82 | 0.080 |
Why?
| | Rats | 1 | 2016 | 4958 | 0.070 |
Why?
| | Ovarian Neoplasms | 1 | 2012 | 388 | 0.070 |
Why?
| | Retinoblastoma Protein | 3 | 2016 | 52 | 0.070 |
Why?
| | Mice, Inbred C57BL | 1 | 2016 | 4689 | 0.070 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2016 | 57 | 0.070 |
Why?
| | Gene Expression Profiling | 1 | 2012 | 1518 | 0.060 |
Why?
| | MutS Homolog 3 Protein | 1 | 2004 | 2 | 0.060 |
Why?
| | Acid Anhydride Hydrolases | 1 | 2004 | 5 | 0.060 |
Why?
| | MutL Protein Homolog 1 | 1 | 2004 | 9 | 0.060 |
Why?
| | MutS Homolog 2 Protein | 1 | 2004 | 12 | 0.060 |
Why?
| | Culture Media, Serum-Free | 1 | 2004 | 42 | 0.060 |
Why?
| | Rad51 Recombinase | 1 | 2004 | 14 | 0.060 |
Why?
| | DNA Repair Enzymes | 1 | 2004 | 22 | 0.060 |
Why?
| | Base Sequence | 2 | 2005 | 2114 | 0.060 |
Why?
| | Transcription Factors | 2 | 2018 | 1528 | 0.060 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2005 | 270 | 0.050 |
Why?
| | Interleukin-2 | 1 | 2005 | 413 | 0.050 |
Why?
| | E2F3 Transcription Factor | 1 | 2023 | 8 | 0.050 |
Why?
| | Polycomb-Group Proteins | 1 | 2023 | 29 | 0.050 |
Why?
| | DNA Replication | 1 | 2004 | 202 | 0.050 |
Why?
| | Molecular Sequence Data | 2 | 2005 | 2785 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2012 | 3531 | 0.050 |
Why?
| | Cell Division | 1 | 2004 | 758 | 0.050 |
Why?
| | Telomerase | 1 | 2005 | 206 | 0.050 |
Why?
| | Female | 5 | 2016 | 59466 | 0.050 |
Why?
| | Lung Neoplasms | 1 | 2014 | 2177 | 0.050 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2004 | 367 | 0.050 |
Why?
| | Neoplasm Transplantation | 2 | 2014 | 228 | 0.050 |
Why?
| | Neoplasm Proteins | 1 | 2004 | 384 | 0.050 |
Why?
| | Lysine | 1 | 2023 | 242 | 0.050 |
Why?
| | Carrier Proteins | 1 | 2004 | 695 | 0.040 |
Why?
| | Transplantation, Heterologous | 2 | 2012 | 181 | 0.040 |
Why?
| | Serum | 2 | 2012 | 57 | 0.040 |
Why?
| | Mice, SCID | 2 | 2012 | 314 | 0.040 |
Why?
| | Adenovirus E1A Proteins | 2 | 2012 | 11 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2005 | 1313 | 0.040 |
Why?
| | Protein Binding | 3 | 2012 | 1889 | 0.040 |
Why?
| | ADP-Ribosylation Factors | 1 | 2018 | 16 | 0.040 |
Why?
| | Peptides | 1 | 2023 | 848 | 0.040 |
Why?
| | Dimerization | 1 | 2018 | 176 | 0.040 |
Why?
| | T-Lymphocytes | 1 | 2005 | 1736 | 0.040 |
Why?
| | Ectopic Gene Expression | 1 | 2016 | 4 | 0.040 |
Why?
| | RNA Interference | 1 | 2018 | 433 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 535 | 0.030 |
Why?
| | Claudins | 1 | 2014 | 24 | 0.030 |
Why?
| | Genes, Transgenic, Suicide | 1 | 2014 | 7 | 0.030 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2014 | 102 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 299 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2014 | 620 | 0.030 |
Why?
| | Tumor Protein p73 | 1 | 2012 | 14 | 0.030 |
Why?
| | Genetic Therapy | 1 | 2014 | 257 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2014 | 531 | 0.020 |
Why?
| | Culture Media | 1 | 2012 | 155 | 0.020 |
Why?
| | Etoposide | 1 | 2012 | 148 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2014 | 1143 | 0.020 |
Why?
| | Antibody Specificity | 1 | 2012 | 176 | 0.020 |
Why?
| | Adenoviridae | 1 | 2012 | 184 | 0.020 |
Why?
| | RNA, Messenger | 2 | 2012 | 2552 | 0.020 |
Why?
| | Point Mutation | 1 | 2012 | 216 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2012 | 345 | 0.020 |
Why?
| | Antioxidants | 1 | 2014 | 530 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2012 | 337 | 0.020 |
Why?
| | Transfection | 1 | 2012 | 866 | 0.020 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 2009 | 64 | 0.020 |
Why?
| | E2F4 Transcription Factor | 1 | 2008 | 6 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2012 | 1083 | 0.020 |
Why?
| | Mesoderm | 1 | 2009 | 138 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2014 | 1076 | 0.020 |
Why?
| | Epithelium | 1 | 2009 | 295 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2009 | 555 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1629 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2009 | 522 | 0.020 |
Why?
| | Cyclin D | 1 | 2005 | 5 | 0.020 |
Why?
| | Cyclin D1 | 1 | 2005 | 61 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2005 | 72 | 0.020 |
Why?
| | Cyclins | 1 | 2005 | 78 | 0.020 |
Why?
| | Gene Silencing | 1 | 2005 | 171 | 0.020 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2005 | 111 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2009 | 1947 | 0.010 |
Why?
| | Gene Expression | 1 | 2009 | 1421 | 0.010 |
Why?
| | Cell Cycle | 1 | 2005 | 542 | 0.010 |
Why?
| | Binding Sites | 1 | 2005 | 1168 | 0.010 |
Why?
| | Up-Regulation | 1 | 2005 | 807 | 0.010 |
Why?
| | Models, Biological | 1 | 2005 | 1620 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2005 | 2186 | 0.010 |
Why?
| | Mutation | 1 | 2005 | 3344 | 0.010 |
Why?
| | Male | 1 | 2009 | 55554 | 0.000 |
Why?
|
|
Iwanaga's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|